Researchers are engineering immune cells to take aim at solid tumors.Over the past few years, the treatment of some hard-to-treat blood cancers has been revolutionized by therapies based on engineered T cells, which leverage the patient’s own immune system to destroy cancerous cells. But until recently researchers haven’t had much luck developing these T-cell therapies—called […]
